| INTRODUCTION
Mucous membrane pemphigoid (MMP), formerly called cicatricial pemphigoid, is a rare chronic autoimmune subepithelial blistering disorder that predominantly involves the mucous membranes. 1, 2 The skin is affected in approximately 20% of cases. 3 Clinically, MMP patients have blisters and erosions, most frequently in the oral mucosa, followed in frequency by the ocular conjunctiva, the anogenital area, the nose and the laryngeal, pharyngeal and esophageal mucosae. 4 In some cases, lesions heal with scarring that may result in blindness or severe airway obstruction if left undetected and untreated. 4, 5 Histopathological analysis demonstrates subepidermal separation associated with inflammatory cell infiltrates. Direct immunofluorescence (DIF) reveals linear deposits of IgG and/or C3, and sometimes IgA, at the basement membrane zone (BMZ). 6 Patients have autoantibodies against multiple BMZ proteins, for example, collagen XVII (COL17, also called BP180), laminin 332, integrin α6/β4, and collagen VII (COL7). Of these, laminin 332 and the C-terminus of COL17 are the major targeted autoantigens. 1, 7 MMP is diagnosed from the combined clinical, histological, and immunological findings. It is not easy to confirm a diagnosis of MMP for several reasons. It is difficult to obtain biopsy specimens from lesional tissue for histological analysis. 6 Furthermore, circulating autoantibodies are often undetected due to their low titers. 3 Recently, we reported that the oral mucosa is a more feasible substrate than skin for the detection of autoantibodies and autoantigens in MMP patients. 8 However, obtaining normal human oral mucosa tends to be more difficult than obtaining normal human skin, because oral mucosal specimens tend to be accompanied by scarring with recurring infection. 
| The generation of immortalized normal human oral mucosal keratinocytes (immortalized OMKs)
Primary OMKs were generated from a healthy volunteer. Briefly, the specimen was obtained from buccal mucosa, then incubated in dispase (1000 PU/mL, Wako, Osaka, Japan) overnight at 4°C to separate the epidermis from the dermis. The epidermis was treated with trypsin (Wako, Osaka, Japan), and then the cell suspension was centrifuged. The pellet was resuspended in keratinocyte growth medium (KGM-Gold, Lonza, Basel, Switzerland) and cultured at 37°C under 5% CO 2 . To immortalize the OMKs, we used E6/E7 proteins of HPV.
Briefly, E6/E7 genes of HPV were inserted into a pL VSIN-EF1 α-Pur
Vector (TaKaRa, Shiga, Japan) and then transfected to Lenti-X 293T
(TaKaRa, Shiga, Japan) using the TransIT-293 Transfection Reagent 
| Immunofluorescence analysis
For DIF, perilesional buccal mucosal specimens were taken using a 4-mm punch biopsy tool under local anesthesia. 5-μm-thick frozen sections were stained with FITC-conjugated goat antihuman IgG, IgA, IgM and C3 (1:100, DakoCytomation, Glostrup, Denmark). Indirect immunofluorescence (IIF) was performed using normal human skin and normal human oral mucosa obtained from healthy volunteers. For the 1 mol/L NaCl-split skin IIF, the skin specimens were treated with 1 mol/L NaCl for 24 hours at 4°C. 
| Immunoblotting
Immunoblotting to detect autoantibodies and to identify autoantigens was performed as described previously. 10 Briefly, cell lysates were prepared using RIPA buffer (Thermo Fisher Scientific, Rockford, IL) containing protease inhibitor cocktails (Sigma-Aldrich, St. Louis, MO immortalized OMKs. There were no significant differences in the protein expression levels of COL17, laminin α3, laminin β3, laminin 
| Case presentation
An 85-year-old woman was admitted to our hospital with a 1-year history of painful erosions on the oral mucosa. Physical examinations revealed multiple erosions on the hard palate and the bilateral buccal mucosa ( Figure 4A-C) . DIF from perilesional buccal mucosa showed linear deposits of IgG and C3 at the BMZ ( Figure 4D , E). IIF using normal human skin did not detect autoantibodies against the BMZ in the patient's serum ( Figure 4F ). 1 mol/L NaCl-split skin IIF showed autoantibodies reacting neither to the dermal nor to the epidermal side of the split ( Figure 4G ). Chemiluminescent enzyme immunoassays (CLEIAs)
for anti-COL17-NC16A, anti-desmoglein 1, and anti-desmoglein 3 were all negative. To detect antibodies targeting BMZ components, we used normal human oral mucosal substrate for IIF. As we expected, the IIF using oral mucosa showed IgG deposits at the BMZ ( Figure 4H ).
Immunoblotting using immortalized OMK lysates clearly detected mul- divisions for primary keratinocytes, so they cannot be used forever.
Therefore, we attempted to use HPV to immortalize the OMKs, and we successfully identified the autoantigens of MMP using cell lysates from immortalized OMKs.
There are many advantages to using immortalized cell lines 0%-21% and 2%-30% of MMP sera reacted to integrin β4 and laminin 332, respectively. [15] [16] [17] Patients with autoantibodies to full-length COL17 and to LAD1 demonstrate severe clinical diseases. 15 However, the present patient showed no obvious lesions other than in the oral cavity and responded to minocycline combined with topical corticosteroid.
LAD1 is an ectodomain of COL17 that is cleaved in the NC16A domain, and it is a major targeted autoantigen in linear IgA dermatosis (LAD). LAD is a rare autoimmune subepidermal blistering disease characterized by linear deposits of IgA at the BMZ. LAD patients have IgA autoantibodies that preferentially react with LAD1 and the 97-kD LABD97, but not with full-length COL17. 18 Recently, our group reported that COL17 processing within the NC16A domain and NC4 induces dynamic conformational changes that generate new epitopes on COL17. 18 The IgG autoantibodies in the present case showed behaviors characteristic of LAD autoantibodies. The
IgG autoantibodies in this case may have reacted with epitopes that were newly induced by the processing of COL17.
In summary, we demonstrated that cell lysates of immortalized OMKs are reliable substrates for the detection of MMP autoantigens. This novel immunoblotting analysis promises to contribute to the diagnosis of MMP.
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